|
 |
Advances in Dermatology
The New York University Post-Graduate Medical School
|
Course Directors: Seth J. Orlow, MD, PhD, Bruce E. Strober, MD, PhD and
Elizabeth K. Hale, MD
Dermatologists applying for dermatologic surgery privileges in hospitals,
ambulatory surgery centers, or outpatient clinics should be able to demonstrate
appropriate training, competence, and experience in many procedures. They
must appropriately select patients for either surgical or cosmetic procedures.
Training may be acquired through residency training, post-residency training
at formal courses, supervised instruction by skilled dermatologists, dermatologic
surgeons or other practitioners, and practical experience.
Also, there is a growing demand for dermatologists to be competent in the
diagnosis and treatment of diseases of the skin. Specifically, fewer dermatologists
are able to diagnose complex medical dermatologic conditions and subsequently
use both conventional and novel therapeutics that possess greater efficacy and,
more importantly, the ability to positively alter the lives of patients with serious
cutaneous disease.
Additionally, dermatology is a fast-moving specialty, with novel advances
in medical, surgical, and procedural/cosmetic dermatology made yearly.
Specifically, newer medications and modalities have been introduced
that promise (and often deliver) better outcomes with fewer risks. As well,
newer disease scenarios have arisen and this program addresses the best
approaches to better health-related outcomes.
| CREDITS |
Earn up to 11 AMA PRA Category 1 Credits™ |
| CE RELEASE |
July 6, 2008 |
| CE EXPIRE |
July 6, 2011 |
|
|
|
 |
|
| Item No |
Media (Can't decide on a format?) |
Price |
Purchase |
| 634DD |
Video - DVD: Package includes 5 Advances in Dermatology DVDs with carrying case, a comprehensive course syllabus on CD-ROM, and a program evaluation. |
$395.00 |
| 634AUP |
Additional User Package: Package includes a comprehensive program syllabus on CD-ROM and a program evaluation (initial video purchase required.) |
$250.00 |
| |
|
| Special pricing for clinic-wide orders or for group subscriptions/purchases. Minimum order quantities apply for eligible discounts. For further information and pricing estimates, contact Kyle Jackson at 1-800-952-0690 x3075. |
|
Target Audience
This program is for practitioners who care for people with skin disease, including dermatologists, dermatologic surgeons, and residents in dermatology.
Topics & Speakers
MEDICAL DERMATOLOGY
Treating Head Lice Without
a Prescription
Seth J. Orlow, MD, PhD
Hair Loss inWomen
Jerry Shapiro, MD, FRCPC
Update on theMolecular Biology
of Hair Growth
David Chu, MD, PhD
Treatment Options for Hyperpigmentation
Roopal Kundu, MD
Biologic Therapy for Psoriasis: Update
Bruce E. Strober, MD, PhD
Rationale for the New
Treatments in
Cutaneous Lupus
Andrew G. Franks, Jr., MD
Interesting Cases of Allergic
Contact Dermatitis
Ronald R. Brancaccio, MD
Controversies in Contact Dermatitis
David E. Cohen, MD, MPH
Novel Approaches in the Treatment of
Urticaria and Angioedema
Nicholas A. Soter, MD
Atopic Eruption of Pregnancy:
What’s in a Name?
Miriam Pomeranz, MD
The Comeback of Syphilis
Miguel R. Sanchez, MD
Leprosy in New York City
William R. Levis, MD
Novel Treatments for Advanced
Cutaneous
T-cell Lymphoma
Kenneth Hymes, MD
Diagnosis and Treatment of
Cutaneous
B-cell Lymphoma
Jo-Ann Latkowski, MD
PEDIATRIC DERMATOLOGY
Filaggrin and Its Clinical Relevance
Julie Schaffer, MD
Hormonal Therapy for Acne
Helen Shin, MD
Childhood Acne: Update on
Evaluation
and Management
Julie Cantatore-Francis, MD
DERMATOLOGIC SURGERY
The Anticoagulant Controversy
Julie K. Karen, MD
Managing Complications in
Dermatologic Surgery
Lance Brown, MD
Non-surgical Treatment Options
for Lentigo Maligna
Vicki J. Levine, MD
Management of the Sub-Optimal Scar
Elizabeth K. Hale, MD |
COSMETIC DERMATOLOGY
AND
LASER SURGERY
Teens and Tanning Attitudes
Robin Ashinoff, MD
The Cosmetic Consultation
Jessie Cheung, MD
Emerging Trends in Injectables
Deborah S. Sarnoff, MD
Body Shaping
Anne Chapas, MD
What’s New in Laser Resurfacing
Leonard Bernstein, MD
Thoughts on Liposuction
Rhoda Narins, MD
PIGMENTED LESIONS AND
MELANOMA I
The Diagnostic Conundrum of the
Small Melanoma
Robert Friedman, MD
In-Vitro Assessment of UV Protection by
Clothing and Sunscreen
StevenWang, MD
Total Body Cutaneous Examination is Not
Time Consuming
Ashfaq Marghoob, MD
The Doctor-Patient Relationship:
Giving Bad News
Caron Grin, MD
Regional Dermatology Training Center,
Moshi, Tanzania
Henning Grossman, MD
PIGMENTED LESIONS AND
MELANOMA II
Thoughts and Controversies on the Primary
Prevention of Melanoma
Jason Rivers, MD
Advances in Therapies forMelanoma
Gary Rogers, MD
Back to the Future: Translational Research
in Melanoma
David Polsky, MD, PhD
What’s New in Photoprotection?
Darrell S. Rigel, MD
A Lifetime in Cutaneous Oncology
AlfredW. Kopf, MD,
Professor Emeritus, Dermatology
NYU School of Medicine |
Course Directors
Seth J. Orlow, MD, PhD
Bruce E. Strober, MD, PhD
Elizabeth K. Hale, MD
|
Guest Faculty |
Leonard Bernstein, MD
Clinical Assistant
Professor of Dermatology
Weill Medical College
Cornell University,
Medical Center
New York, NY
Caron Grin, MD
Clinical Professor of Dermatology
University of Connecticut,
School of Medicine
Farmington, CT
Henning Grossmann, MD
Past Principal, RDTC
Kilimanjaro Christian, Medical Center
Tanzania
|
Ashfaq Marghoob, MD
Associate Clinical Professor
Memorial Sloan-Kettering, Cancer Center
New York, NY
Jason Rivers, MD
Clinical Professor
University of British Columbia
Vancouver, BC, Canada
Gary Rogers, MD
Professor of Surgery and Dermatology
Tufts School of Medicine
Boston, MA
Steven Wang, MD
Assistant Clinical Professor
Memorial Sloan-Kettering, Cancer Center
New York, NY |
NYU School of Medicine Dermatology Faculty*
|
Alfred W. Kopf, MD
Professor Emeritus, Dermatology
Robin Ashinoff, MD
Ronald R. Brancaccio, MD
Lance Brown, MD
Julie Cantatore-Francis, MD
Anne Chapas, MD
Jessie Cheung, MD
David Chu, MD, PhD
David E. Cohen, MD, MPH
Andrew G. Franks, Jr., MD
Robert Friedman, MD
Kenneth Hymes, MD
Department of Medicine (Hematology)
*Unless otherwise noted
|
Julie K. Karen, MD
Roopal Kundu, MD
Jo-Ann Latkowski, MD
Vicki J. Levine, MD
William R. Levis, MD
Rhoda Narins, MD
David Polsky, MD, PhD
Miriam Pomeranz, MD
Darrell S. Rigel, MD
Miguel R. Sanchez, MD
Deborah S. Sarnoff, MD
Julie Schaffer, MD
Helen Shin, MD
Jerry Shapiro, MD, FRCPC
Nicholas A. Soter, MD |
Learning Objectives
After viewing this program, participants will be able to:
- Correctly diagnose dermatologic conditions that are amenable to surgical or
cosmetic intervention and
select appropriate treatment
- Apply state-of-the-art interventions when co-morbid conditions are present
utilizing good data that take into account contraindications to the use of
specific therapeutic modalities in patients with complex medical
dermatological conditions
- Critically evaluate evidenced-based studies examining the use of novel
therapeutics for the treatment of cutaneous disease and apply these techniques
to your clinical practice
- Demonstrate proper patient selection and the use of emerging modalities
for the treatment of photoaging with filler substances, lasers, and other
light sources
- Evaluate interventions based on epidemiology, histopathology, and clinical
research for patients with skin cancer
- Discuss the advances in interventions for inflammatory dermatitis and
blistering diseases
Accreditation
The NYU Post-Graduate Medical School is accredited by the Accreditation Council for Continuing
Medical Education to provide continuing medical education for physicians.
Credit Designation
The NYU Post-Graduate Medical School designates this educational activity for a maximum
of 11 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.
Release date: July 6, 2008 Credits expire: July 6, 2011
CME credit is obtained upon successful completion of a program evaluation. A $65 processing fee must accompany the completed evaluation.
Faculty Disclosure
Disclosure of faculty and commercial relationships, as well as the discussion of unlabeled or
unapproved use of any drug, device or procedure by the faculty has been made known. Full disclosure of faculty is
listed in the syllabus.
|
|
| |
|
|
|
|
